𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Childhood Hodgkin's disease in Campinas, Brazil

✍ Scribed by Faria, Sérgio L.; Vassallo, José; Cosset, Jean Marc; Brandalise, Sílvia R.


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
453 KB
Volume
26
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Little clinical information about Hodgkin's disease in children is available from poor countries. The object of this study is to evaluate our data in Campinas, Brazil and hope "to make one dot on the geographic map of this disease more clear." Patients and Methods: Between 1978 and 1988, 46 patients under the age of 17 years with biopsy-proven Hodgkin's Disease (HD) were referred for evaluation at Centro Boldrini in Campinas, S%o Paul0 state, in Brazil. Thirtyseven of them were treated and followed-up only at this Center and are the subjects of this analysis. All the original histological slides were obtained, reviewed, and classified according to the Rye system. Staging procedures included exploratory laparotomy in 33 of 37 children, but none had lymphangiography. Treatment was individualized until January 1986 when the German protocol was adopted. Results: Nineteen cases were classified as nodular sclerosis, 14 as mixed cellularity, and three as lymphocyte depleted. Mean age was 7 years; male/ female ratio was 2:l. Fifty percent were advanced stages I l l and IV and 46% (17/37) had at least one of the systemic B symptoms. Mean follow-up was 81 months (range from 41 to 174 months). Five-year actuarial overall survival was 78%. Two children (5%) had acute myeloid leukemia at 25 and 49 months after diagnosis. Conclusions: Although distribution of histological subtypes of our cases is similar to other reports in developed countries, as well as percentage of advanced stages III/IV, our patients fared worse when compared to those reports. The reason for this continues to remain unclear but it does not seem to be related to histology subtypes. 0 I%Wiley-Liss, inc.


📜 SIMILAR VOLUMES


Down syndrome and Hodgkin disease in chi
✍ Sandoval, Claudio; Hudson, Melissa M.; Ozkaynak, M. Fevzi; Tugal, Oya; Jayabose, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Down syndrome; Hodgkin disease; therapy; treatment complications Children with Down syndrome are at increased risk for developing acute leukemia of both the lymphoblastic and myeloid types [1]. Although the exact mechanism(s) underlying the malignant transformation are unknown, immunodeficiency and

Childhood Hodgkin's disease in Uganda. A
✍ Dr. C. L. M. Olweny; E. Katongole-Mbidde; C. Kiire; S. K. Lwanga; I. Magrath; J. 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-yearsold were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available. Thirty-eight percent had early stage disease (stages I-IIIA). Prolonged first remissions were achiev

Gonadal function following chemotherapy
✍ Mackie, E. J.; Radford, M.; Shalet, S. M. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

Gonadal function was assessed in 101 postpubertal subjects after chemotherapy for childhood Hodgkin's disease. All had received ChlVPP (chlorambucil, vinblastine, procarbazine, and prednisolone) chemotherapy alone, with no radiotherapy below the diaphragm. Go- nadotropin levels were available in 46

Hodgkin's disease in Kenya
✍ Malkit S. Riyat 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views